510(k) Report

510(k) · Cleared

Cleared

Rapidone - Marijuana Test

K990818510(k) TraditionalCleared Jul 7, 1999118-day reviewClass II21 CFR 862.3870

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

American Bio Medica Corp. · LDJ Enzyme Immunoassay, Cannabinoids

Cleared on Jul 7, 1999 after a 118-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below). 1 later device descends from it.

Decided
Jul 7, 1999
Review
118 days
Class
Class II
Product code
LDJ
Recalls
None
Predicates
1

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2000: 1 descendant cleared1995200020052010201520202025
  1. This deviceK990818 Rapidone - Marijuana TestAmerican Bio Medica Corp. · 1999
  2. Descendant · cites it directly · 0 of its ownK993151 Radid Drug Screen 5-Panel TestAmerican Bio Medica Corp. · 2000

Most influential descendants

Showing 1 of 1 · See all
  • K993151Radid Drug Screen 5-Panel TestAmerican Bio Medica Corp. · 2000 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K990818Rapidone - Marijuana TestAmerican Bio Medica Corp.1999—
+1K993151Radid Drug Screen 5-Panel TestAmerican Bio Medica Corp.2000—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200010
FIG. 1 — Lineage of K990818, 1999–2000Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LDJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LDJ device

  1. #1 K232732 Rapid Marijuana (THC) Test Strip 20, Rapid…score 9.4 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
Kept off the family treeK971959Forefront Diagnostics, Inc. ‘Instacheck’ Drug Screen - Marijuana Test
Not in FDA’s 510(k), De Novo or PMA lists as we hold them (a misreading, a typo, or a number FDA does not list), so it is kept off the family tree
Summary page 1
…the requirements of 21 CFR 807.92. » The assigned 510(k) is: K990818 Predicate Device: Forefront Diagnostics, Inc. ‘Instacheck’ Drug Screen -Marijuana Test (510(k) No. K971959) Test Description: The assay employed in the ‘RapidOne’~ Marijuana Test is based on the same principle of highly specific react…

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K993151Radid Drug Screen 5-Panel TestAmerican Bio Medica Corp.20000

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K993151 (American Bio Medica Corp., 2000) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LDJ devices

LDJ Enzyme Immunoassay, Cannabinoids: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LDJ

2in 2024

2008: 22009: 12011: 42012: 42013: 32014: 22015: 32016: 12019: 12023: 12024: 2
2007high 4 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LDJ

48in 2015

2011: 219 days median2012: 193 days median2013: 162 days median2015: 48 days median
2007high 219 (2011) · low 48 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LDJ

1in 2023

2008: 42023: 1
2007high 4 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LDJ

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code LDJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—40
20091—00
20100—00
2011421900
2012419300
2013316200
20142—00
201534801
20161—00
20170—00
20180—00
20191—00
20200—00
20210—00
20220—00
20231—10
20242—00
20250—00
20260—0—

What is it indicated for?

‘RapidOne’ - Marijuana Test is a one-step, lateral flow immunoassay for the detection of marijuana in urine. ‘RapidOne’ - Marijuana Test is intended for use in the qualitative detection of marijuana metabolite, 11-nor-9-carboxy-delta-9-THC in human urine at 50 ng/ml. ‘RapidOne’ - Marijuana Test is intended for professional use. It is not intended for over the counter sale to non-professionals. The assay is easy to perform, but should not be used without…

Read the full statement (163 words)

‘RapidOne’ - Marijuana Test is a one-step, lateral flow immunoassay for the detection of marijuana in urine. ‘RapidOne’ - Marijuana Test is intended for use in the qualitative detection of marijuana metabolite, 11-nor-9-carboxy-delta-9-THC in human urine at 50 ng/ml.

‘RapidOne’ - Marijuana Test is intended for professional use. It is not intended for over the counter sale to non-professionals. The assay is easy to perform, but should not be used without proper supervision. This immunoassay is a simplified qualitative screening method that provides only a preliminary result for use in determining the need for additional or confirmatory testing, i.e., gas-chromatography/mass spectrometry (GC/MS) or HPLC.

‘RapidOne’ - Marijuana Test provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a more confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K990818: Rapidone - Marijuana Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K990818

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026